You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cytotoxic chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cytotoxic Chemotherapy and PARP Inhibition on Genomic Contexture

Recruiting
  • Ovarian Cancer
    • Athens, Greece
      Adamantia Nikolaidi
    Aug 9, 2022

    Metastatic Breast Cancer, Tumor, Muscle Tumors Trial in Colorado Springs (Method(s)1 Attribution, Method(s)2 Attribution,)

    Not yet recruiting
    • Metastatic Breast Cancer
    • +3 more
    • Method(s)1 Attribution
    • Method(s)2 Attribution,
    • Colorado Springs, Colorado
      PNAF Medical
    Nov 23, 2023

    Advanced Urothelial Carcinoma Trial in Bern (Magrolimab, Cisplatin, Gemcitabine)

    Not yet recruiting
    • Advanced Urothelial Carcinoma
    • Bern, Switzerland
      University Hospital Insel
    Feb 20, 2023

    Evidence-based Walking Program in Cancer Pts 60+ During

    Completed
    • Breast Cancer
    • +2 more
    • Walk With Ease Program
    • Collect Blood, GA and Other Survey Tools
    • Chapel Hill, North Carolina
      University of North Carolina Cancer Hospital
    Feb 2, 2023

    Cognitive Impairment in Colorectal Cancer Patients Receiving

    Recruiting
    • Neoplasm, Colorectal
    • +7 more
      • Fort Wayne, Indiana
        Parkview Cancer Institute
      Nov 11, 2021

      Chemotherapy-Related Complications

      Recruiting
      • Lymphoma
      • Chemotherapeutic Toxicity
      • Blood test for determination of CHIP
      • Toronto, Ontario, Canada
        Sunnybrook Health Sciences Centre
      Aug 3, 2022

      Chemotherapeutic Toxicity, Chemotherapeutic Agent Toxicity, Chemo Effect Trial in Hershey (Educational Brochure)

      Recruiting
      • Chemotherapeutic Toxicity
      • +2 more
      • Educational Brochure
      • Hershey, Pennsylvania
        Penn State Cancer Institute
      Jan 14, 2022

      NSCLC Trial (Pemetrexed, Carboplatin, Pembrolizumab, Paclitaxel, Carboplatin, Pembrolizumab)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Pemetrexed, Carboplatin, Pembrolizumab
      • Paclitaxel, Carboplatin, Pembrolizumab
      • (no location specified)
      Jul 8, 2021

      Febrile Neutropenia, Solid Tumor, Hematologic Tumors Trial in Clamart, Le Kremlin-Bicêtre (NEUTROSIS)

      Completed
      • Febrile Neutropenia
      • +2 more
      • NEUTROSIS
      • Clamart, France
      • +2 more
      May 2, 2022

      Acute Myeloid Leukemia Trial in Baltimore (Decitabine, talazoparib)

      Active, not recruiting
      Has Results
      • Acute Myeloid Leukemia
      • Baltimore, Maryland
        University of Maryland Greenebaum Comprehensive Cancer Center
      May 31, 2022

      Stage II-III Breast Cancer Trial in Shenyang (cytotoxic chemo (docetaxel or epirubicin or cyclophosphamide or carboplatin),

      Recruiting
      • Stage II-III Breast Cancer
      • cytotoxic chemotherapy (docetaxel or epirubicin or cyclophosphamide or carboplatin)
      • +2 more
      • Shenyang, Liaoning, China
      • +1 more
      Aug 3, 2022

      Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)

      Active, not recruiting
      • Acute Lymphocytic Leukemia
      • Lymphoma
      • Biological/Genetically Modified T cells
      • Cyclophosphamide-based chemotherapy
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jan 3, 2023

      MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

      Recruiting
      • Myelodysplastic Syndromes, de Novo
      • +10 more
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Jan 23, 2023

      Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)

      Not yet recruiting
      • Localized Osteosarcoma
      • +3 more
      • Cabozantinib S-malate
      • +7 more
      • (no location specified)
      Jan 4, 2023

      Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)

      Not yet recruiting
      • Epithelial Ovarian Cancer
      • Ovarian Carcinoma
      • XP-DC vaccinations
      • Nijmegen, Gelderland, Netherlands
        Radboud University Medical Center
      Mar 6, 2023

      NSCLC (NSCLC) Trial in Seoul (Immunnotherapy group)

      Recruiting
      • Non-small Cell Lung Cancer (NSCLC)
      • Immunnotherapy group
      • Seoul, Korea, Republic of
        Department of Medicine, Samsung Medical Center, Sungkyunkwan Uni
      Aug 5, 2021

      NSCLC Trial in Seoul (SNK01 (Super Natural Killer Cells 01), GC, Cetuximab)

      Recruiting
      • Non-small Cell Lung Cancer
      • SNK01 (Super Natural Killer Cells 01)
      • +2 more
      • Seoul, Songpa-gu, Korea, Republic of
        Asan Medical Center
      Jul 15, 2021

      Metastatic Pancreatic Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)

      Completed
      • Metastatic Pancreatic Cancer
      • Ad5-yCD/mutTKSR39rep-hIL12
      • Detroit, Michigan
        Henry Ford Hospital
      Feb 15, 2022

      Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)

      Not yet recruiting
      • Localized Osteosarcoma
      • +3 more
      • Bone Scan
      • +7 more
      • (no location specified)
      Jan 18, 2023

      Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer Trial in Worldwide (Administration of

      Recruiting
      • Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
      • Administration of ceralasertib in combination with carboplatin
      • +3 more
      • Duarte, California
      • +26 more
      Aug 17, 2022

      Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo, East Hills, West Islip (biological, drug, other)

      Active, not recruiting
      • Recurrent Plasma Cell Myeloma
      • Refractory Plasma Cell Myeloma
      • Abatacept
      • +3 more
      • Buffalo, New York
      • +2 more
      Dec 22, 2022

      Metastatic Tumor Trial in Prince George, London, Montréal (radiation, drug, other, procedure)

      Not yet recruiting
      • Metastatic Tumor
      • Palliative Radiotherapy
      • +9 more
      • Prince George, British Columbia, Canada
      • +2 more
      Feb 6, 2023

      EGFR Positive NSCLC Trial in Korea, Republic of (EGFR)

      Active, not recruiting
      • EGFR Positive Non-small Cell Lung Cancer
      • Anyang, Gyeonggi-do, Korea, Republic of
      • +7 more
      Jul 13, 2021

      Merkel Cell Carcinoma Trial in United States (Avelumab, N-803, haNK™)

      Terminated
      • Merkel Cell Carcinoma
      • Avelumab
      • +2 more
      • San Francisco, California
      • +4 more
      Jan 7, 2022

      Advanced Colon Adenocarcinoma, Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma Trial in Duarte

      Active, not recruiting
      • Advanced Colon Adenocarcinoma
      • +24 more
      • Ipilimumab
      • +2 more
      • Duarte, California
        City of Hope Medical Center
      Aug 22, 2022